Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
MOMA Therapeutics
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Revolution Medicines, Inc.
City of Hope Medical Center
Eli Lilly and Company
M.D. Anderson Cancer Center
Hoffmann-La Roche
Duke University
AstraZeneca
Poseida Therapeutics, Inc.
University of Washington
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
TCR2 Therapeutics
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Cancer Research UK
OncoC4, Inc.
National Cancer Institute (NCI)
Tempus AI
University Hospital, Antwerp
Cybrexa Therapeutics
Carisma Therapeutics Inc
NGM Biopharmaceuticals, Inc
ENB Therapeutics, Inc
University Hospital, Geneva